ATE546147T1 - Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung - Google Patents

Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung

Info

Publication number
ATE546147T1
ATE546147T1 AT06736222T AT06736222T ATE546147T1 AT E546147 T1 ATE546147 T1 AT E546147T1 AT 06736222 T AT06736222 T AT 06736222T AT 06736222 T AT06736222 T AT 06736222T AT E546147 T1 ATE546147 T1 AT E546147T1
Authority
AT
Austria
Prior art keywords
treating
methods
heart disease
compositions
preventing cardiomyopathy
Prior art date
Application number
AT06736222T
Other languages
German (de)
English (en)
Inventor
Joseph Metzger
Dewayne Townsend
Soichiro Yasuda
Dan Michele
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE546147T1 publication Critical patent/ATE546147T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06736222T 2005-02-25 2006-02-27 Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung ATE546147T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65657005P 2005-02-25 2005-02-25
PCT/US2006/006862 WO2006091941A2 (en) 2005-02-25 2006-02-27 Compositions and methods for treating and preventing cardiomyopathy and heart disease

Publications (1)

Publication Number Publication Date
ATE546147T1 true ATE546147T1 (de) 2012-03-15

Family

ID=36928113

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06736222T ATE546147T1 (de) 2005-02-25 2006-02-27 Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung

Country Status (8)

Country Link
US (2) US7846426B2 (enExample)
EP (1) EP1853280B1 (enExample)
JP (1) JP5042041B2 (enExample)
AT (1) ATE546147T1 (enExample)
AU (2) AU2006216420B2 (enExample)
CA (1) CA2599219C (enExample)
ES (1) ES2380047T3 (enExample)
WO (1) WO2006091941A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5537152B2 (ja) * 2006-08-01 2014-07-02 フリクサス ファーマシューティカルズ， インコーポレイテッド 慢性進行性心不全のための処置
CA2682234A1 (en) * 2007-04-05 2008-10-16 Phrixus Pharmaceuticals, Inc. Compositions and methods for the treatment of heart failure
US20110052490A1 (en) * 2007-11-29 2011-03-03 Plur0Med, Inc Endoscopic mucosal resectioning using purified inverse thermosensitive polymers
EP2719389B1 (en) * 2007-12-17 2016-07-06 The Regents Of The University Of Michigan Compositions and methods for treating and preventing skeletal muscle deficiencies
US9867547B2 (en) 2012-11-29 2018-01-16 Siemens Healthcare Gmbh System and method to calculate cardiac characteristics
JP2016516825A (ja) * 2013-04-19 2016-06-09 シーダーズ−サイナイ メディカル センター 筋ジストロフィーの治療のためのホスホジエステラーゼ５ａ阻害物質
US20160235781A1 (en) * 2013-10-16 2016-08-18 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
TWI688392B (zh) 2014-07-07 2020-03-21 美商救生筏生物科技公司 無長循環材料之泊洛沙姆組成物以及其製造方法和用途
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
EP3965734A4 (en) * 2019-05-06 2022-12-14 Arshintseva, Elena Valentinovna Method for increasing cancer patient's haemoglobin level

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0576612B1 (en) * 1991-03-19 1999-12-01 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
JPH05178760A (ja) 1991-06-03 1993-07-20 Alpha Therapeutic Corp 心筋梗塞治療剤
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
US6761824B2 (en) * 2000-08-17 2004-07-13 Reeve Lorraine E Process for the fractionation of polymers
WO2002065834A2 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol

Also Published As

Publication number Publication date
AU2006216420B2 (en) 2010-07-15
US20110044935A1 (en) 2011-02-24
EP1853280A4 (en) 2008-10-29
JP2008531598A (ja) 2008-08-14
US8580245B2 (en) 2013-11-12
EP1853280A2 (en) 2007-11-14
AU2010214636A1 (en) 2010-09-16
US7846426B2 (en) 2010-12-07
ES2380047T3 (es) 2012-05-08
EP1853280B1 (en) 2012-02-22
WO2006091941A3 (en) 2007-01-04
CA2599219C (en) 2011-09-20
AU2006216420A1 (en) 2006-08-31
WO2006091941A2 (en) 2006-08-31
US20080260681A1 (en) 2008-10-23
CA2599219A1 (en) 2006-08-31
JP5042041B2 (ja) 2012-10-03

Similar Documents

Publication Publication Date Title
EA200501592A1 (ru) Способы и композиции для введения агонистов trpv1
EA200970446A1 (ru) Связывающиеся с альбумином молекулы и их применение
EA201071178A1 (ru) Усовершенствованные способы гашения нежелательных побочных реакций при патогенной инактивации эритроцитов
DOP2012000314A (es) Compuestos, composiciones de tiocetato y metodos de uso
BR112012032193A2 (pt) composto, composiçoes e métodos de uso de feniltioacetato
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
BR112015006828A8 (pt) composto, ou um sal farmaceuticamente aceitável do mesmo; composição farmacêutica; uso do composto; e método para modular a atividade de uma proteína ire1
EA201500432A1 (ru) Соединения боронатного эфира и его фармацевтические составы
CY1112999T1 (el) Αναστολεις ιου ηπατιτιδας c
EA200901241A1 (ru) Соединения для лечения гепатита с
MX2012009088A (es) Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos.
EA201890516A1 (ru) Клинические композиции
RU2016135039A (ru) Композиция для обработки поверхностных дефектов
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
BRPI0608604B8 (pt) moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
MX2012015063A (es) Metodos y composiciones para mejorar la movilizacion de celulas madre.
EA201100564A1 (ru) Антипролиферативные соединения
EA201170571A1 (ru) Способы и композиции для улучшения когнитивной функции
EA200701799A1 (ru) Транс-каротиноиды, синтез указанных каротиноидов, получение композиций и их применение
EA201100921A1 (ru) Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ
MX2010010726A (es) Composicion de estilizado de cabello.
EA201000105A1 (ru) Химические соединения
RU2014146291A (ru) Способ использования сложных эфиров азелаиновой кислоты для модуляции передачи сигналов, медиируемых биологическими молекулами
EA201190344A1 (ru) Составы для лечения боли в глубоких тканях